XML 93 R65.htm IDEA: XBRL DOCUMENT v3.10.0.1
Collaboration and License Agreements - Mylan Collaboration Agreement (Details)
$ in Millions
9 Months Ended 12 Months Ended
Jan. 08, 2016
USD ($)
Sep. 30, 2018
Dec. 31, 2018
USD ($)
performance_obligation
product_candidate
Dec. 31, 2017
USD ($)
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Number of additional performance obligations | performance_obligation     4  
Mylan Collaboration Agreement        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Number of product candidates | product_candidate     6  
Cash received from milestone payments       $ 60.0
Number of years for ceasing agreement     2 years  
Revenue recognized     $ 31.5  
Percentage of cost sharing arrangement under collaborative and license agreements   50.00% 50.00%  
Milestone payment on collaboration agreement $ 200.0      
Accounting Standards Update 2009 to 2013 | Mylan Collaboration Agreement        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Total arrangement consideration 45.0      
Portion of revised arrangement consideration allocated to the first initial product license as a result of termination of product 8.2      
Portion allocated to second initial product license     $ 7.1  
Deferred revenue amortized to research and development revenue     $ 5.7  
Minimum | Accounting Standards Update 2009 to 2013 | Mylan Collaboration Agreement        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Portion of revised arrangement consideration allocated to each of the three additional product licenses as a result of termination of product 5.7      
Maximum | Accounting Standards Update 2009 to 2013 | Mylan Collaboration Agreement        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Portion of revised arrangement consideration allocated to each of the three additional product licenses as a result of termination of product $ 9.0